Tag: IV Plazomicin
Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI
Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................